Recommendations for osteoarthritis
1Department of Internal Medicine, School of Medicine, Perugia University, Terni, Italy
DOI: 10.22514/sv.2021.203 Vol.17,Issue S1,September 2021 pp.60-60
Submitted: 26 August 2021 Accepted: 06 September 2021
Published: 15 September 2021
Osteoarthritis (OA) represents one of the most important clinical situation characterized by chronic pain (CP), huge number of patients worldwide and large amount of burden for each national health systems.
Moreover, OA is now considered as a syndrome in terms of each articular localization; on the other hands the cartilage remodelling is characterized by an imbalance between degradation and synthesis due to the impact of subchondral bone citokines production.
OA presents mechanic CP, and inflammatory acute pain in the period of inflammatory flare.
The American College of Rheumatology published the “2012 recommendations for the therapy of OA”: NSAIDs, acetaminophen, opioids, intra-articular steroids, as well as intra-articular viscosupplementation are the cornerstones of the pharmacological recommendations, while weight management and exercises are the most important suggestions for non-pharmacological treatments.
The American Academy of Orthopeadic Surgeons published in the 2015 the surgery criteria for OA: both conservative and pharmacological treatments come first the surgical approaches.
It is very important to consider that an early diagnosis of OA and an accurate stadiation of the disease can lead to the early start of a focused therapy, the reduction of evolution towards chronicity, progression, and disability, with a consequent reduction of pain and burden, and, finally, the increasing of quality of life.
Stefano Coaccioli. Recommendations for osteoarthritis. Signa Vitae. 2021. 17(S1);60-60.
Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.
Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.
Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.
Index Copernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.
Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.
Scopus: CiteScore 1.0 (2022) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.
Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.